Another study using antibodies against HER3 and EGFR TKIs show the synergistic effect on cell proliferation in vitro and the inhibition of tumor growth in mouse xenograft models of non-small cell lung cancer [82]. Here, ERBB3 is linked to non-small cell lung carcinoma.